Dyslipidemia

Latest News

Metabolic

Statin Therapy Decisions by Patients and Doctors Compared By Technology

An online technology was developed to assess whether physicians and potential patients who may benefit from statin therapy would come to the same diagnostic conclusion.

ACS

Ezetimibe Plus Statin Therapy Reduces Post-ACS Cardiovascular Event Risk

Researchers evaluated the association between baseline LDL-C and treatment with ezetimibe plus statins in post-acute coronary syndrome.

Metabolic

DPP-4 Inhibitors Lower COVID-19 Mortality in Type 2 Diabetes

Investigators aimed to determine the association of pre-existing DPP-4is use with COVID-19–related outcomes among patients with T2DM.

Metabolic

Statin Initiation Linked to Diabetes Progression and Insulin Utilization

Each individual component of the composite outcome was significantly higher among statin users

General Cardiology

Risk Factors for MACE After First Acute Coronary Syndrome Identified

The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.

Metabolic

Evolocumab Approved for Younger Patients Hypercholesterolemia

The approval of Repatha was also expanded to include patients 10 years of age and older with HoFH.

Metabolic

Pictorial Information on Vascular Age Increased Prescribing of Lipid-Lowering Drugs

A clinical trial found that more lipid-lowering medications were prescribed when physicians were provided with pictorial information of their patients’ vascular age and carotid plaques.

Pediatric Cardiology

Higher Maternal Lipid Profile Tied to Congenital Heart Disease in Offspring

Doubled risk seen for high triglyceride, total/high-density lipoprotein, and apolipoprotein-A1

Metabolic

LDL-C Target Levels Achieved in Diabetes, But High-Intensity Statins Not Frequently Initiated

Patients with diabetes achieve LDL-C levels below recommended target goals, but high-intensity statin treatment appears frequently avoided.

Metabolic

Guidance Issued for Reducing ASCVD Risk in Hypertriglyceridemia

Factors to consider include evaluation of secondary causes, optimization of diet and lifestyle interventions, implementation of statin therapy.